skip to main content

S. 3248 (116th): United States Anti-Doping Agency Reauthorization Act of 2020


The text of the bill below is as of Nov 17, 2020 (Reported by Senate Committee).


II

Calendar No. 594

116th CONGRESS

2d Session

S. 3248

[Report No. 116–301]

IN THE SENATE OF THE UNITED STATES

February 3, 2020

(for himself and Mr. Blumenthal) introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation

November 17, 2020

Reported by , with amendments

Omit the part struck through and insert the part printed in italic

A BILL

To reauthorize the United States Anti-Doping Agency, and for other purposes.

1.

Short title

This Act may be cited as the United States Anti-Doping Agency Reauthorization Act of 2020.

2.

Findings

Congress makes the following findings:

(1)

The United States Anti-Doping Agency—

(A)

is the independent national anti-doping organization of the United States; and

(B)

manages the anti-doping program, results management processes, drug reference resources, and athlete education for all United States Olympic Committee-recognized national governing bodies and the athletes and events of such national governing bodies.

(2)

The United States Anti-Doping Agency contributes to the advancement of clean sport through scientific research, anti-doping education, and outreach programs, and the mission of the United States Anti-Doping Agency is to preserve the integrity of competition and protect the rights of athletes.

(3)

Participation in youth sports has the potential to equip young athletes with important skills and values necessary for success in life, and it is essential that the culture of youth sports emphasizes such skills and values.

(4)

The TrueSport program of the United States Anti-Doping Agency partners with youth sport organizations across the United States to promote sportsmanship, character building, and healthy performance through the use of targeted educational materials designed to promote a positive youth sport experience.

(5)

In modifying the authority of the United States Anti-Doping Agency to include the promotion of the positive values of youth sport, Congress sends a strong signal that the goals of youth sport should include instilling in young athletes the values of integrity, respect, teamwork, courage, and responsibility.

(6)

Due to the unique leadership position of the United States in the global community, adequate funding of the anti-doping and clean sport programs of the United States Anti-Doping Agency is imperative to the preparation for the 2028 Summer Olympic Games, which will be held in Los Angeles, California.

(7)

Increased appropriations for fiscal years 2021 through 2029 would enable the United States Anti-Doping Agency to directly affect the integrity and well-being of sport, both domestically and internationally.

3.

Promotion of youth sports

Section 701(b) of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 2001(b)) is amended—

(1)

in paragraph (4), by striking the period at the end and inserting ; and; and

(2)

by adding at the end the following:

(5)

promote a positive youth sport experience by using a portion of the funding of the United States Anti-Doping Agency to provide educationalby providing educational materials on sportsmanship, character building, and healthy performance for the athletes, parents, and coaches who participate in youth sports.

.

4.

Authorization of appropriations

Section 703 of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 2003) is amended to read as follows:

703.

Authorization of appropriations

There are authorized to be appropriated to the United States Anti-Doping Agency—

(1)

for fiscal year 2021, $15,500,000;

(2)

for fiscal year 2022, $16,200,000;

(3)

for fiscal year 2023, $16,900,000;

(4)

for fiscal year 2024, $17,700,000;

(5)

for fiscal year 2025, $18,500,000;

(6)

for fiscal year 2026, $19,800,000;

(7)

for fiscal year 2027, $22,100,000;

(8)

for fiscal year 2028, $24,900,000; and

(9)

for fiscal year 2029, $23,700,000.

.

5.

Information sharing

Except as otherwise prohibited by law and except in cases in which the integrity of a criminal investigation would be affected, pursuant to the obligation of the United States under Article 7 of the United Nations Educational, Scientific, and Cultural Organization International Convention Against Doping in Sport done at Paris October 19, 2005, and ratified by the United States in 2008, the Attorney General, the Secretary of Homeland Security, and the Commissioner of Food and Drugs shall provide to the United States Anti-Doping Agency any relevant information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

6.

Report on capacity to implement equine anti-doping and medication control program

Not later than 180 days after the date of the enactment of this Act, the United States Anti-Doping Agency shall submit to Congress a report that—

(1)

assesses the capacity of the United States Anti-Doping Agency to implement an equine anti-doping and medication control program; and

(2)

includes—

(A)

recommendations with respect to best practices for design, resources, and any other consideration necessary for the successful implementation of such a program in the United States; and

(B)

recommendations developed in consultation with the National Veterinary Services Laboratories with respect to the appropriate technical standards and best practices for such a program.

November 17, 2020

Reported with amendments